Business
Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Christian Draisbach
NEW YORK, April 07, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Christian Draisbach as a managing director to the healthcare investment banking team. Draisbach will be responsible for advising and supporting clients in the biopharma sector.
About this update from Piper Sandler Companies
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/fc22aae0a19bc00bd38e7774d342c89a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YH28H6Rmn9iY14J6cO.vNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fc22aae0a19bc00bd38e7774d342c89a","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/bOsjd3.q9WNvq8Nwccni4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/fc22aae0a19bc00bd38e7774d342c89a","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEW YORK, April 07, 2025--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Christian Draisbach as a managing director to the healthcare investment banking team. Draisbach will be responsible for advising and supporting clients in the biopharma sector.","length":323,"tagName":"p"},{"type":"text","content":""We are excited for Christian to join our healthcare investment banking team. Christian brings 20 years of experience advising biopharma executives and boards through the lifecycle of their business on complex strategic initiatives and mergers, acquisitions, divestitures and partnership transactions in the U.S., Europe and Asia. During his career, Christian has advised on some of the most relevant strategic transactions in the biopharma sector globally. His transaction experience spans the spectrum from early development-stage private transactions to some of the largest and highest-profile public deals. Adding Christian’s experience and network of relationships to our existing platform will drive the Piper Sandler biopharma M&A business both in the U.S. and abroad," said Peter Day, managing director and global group head of healthcare investment banking at Piper Sandler.","length":897,"tagName":"p"},{"type":"text","content":"Draisbach joins the firm from Centerview Partners where he was a managing director primarily focused on clients in the life sciences and broader healthcare sectors. Earlier in his career, Mr. Draisbach worked at Morgan Stanley in the mergers and acquisitions and financial sponsor coverage grou...